Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0MTUPD
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CytSCA208
|
|||||
| Synonyms |
Monoclonal antibody CA208-cytorhodin-S conjugate
Click to Show/Hide
|
|||||
| Organization |
Aventis SA; Sanofi
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
15
|
|||||
| Antibody Name |
CA208
|
Antibody Info | ||||
| Antigen Name |
Pregnancy-specific beta-1-glycoprotein 2 (PSG2)
|
Antigen Info | ||||
| Payload Name |
Cytorhodin S
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 2-alpha (TOP2A)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
